Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats

Fertility and Sterility

Volumn 89, Issue 5 SUPPL., 2008, Pages 1384-1389

  Pluchino, Nicola ^a   Lenzi, Elena ^a   Casarosa, Elena ^a   Cela, Vito ^a   Begliuomini, Silvia ^a   Ninni, Filippo ^a   Freschi, Letizia ^a   Luisi, Stefano ^a   Genazzani, Andrea Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

allopregnanolone; beta endorphin; central nervous system; Dydrogesterone; rats

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; BETA ENDORPHIN; DYDROGESTERONE; ESTRADIOL VALERATE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; COMPARATIVE STUDY; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HORMONE BLOOD LEVEL; HYPOTHALAMUS; NEUROENDOCRINE SYSTEM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; BETA-ENDORPHIN; BRAIN; BRAIN CHEMISTRY; DYDROGESTERONE; ESTRADIOL; FEMALE; OVARIECTOMY; PREGNANOLONE; RATS; RATS, WISTAR;

EID: 43549087124     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.077     Document Type: Article

References (26)

1. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8 (2005) 3-63
2. Nilsen J., and Brinton R.D. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci 100 (2003) 10506-10511
3. Pluchino N., Luisi M., Lenzi E., Centofanti M., Begliuomini S., Freschi L., et al. Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin. J Steroid Biochem Mol Biol 102 (2006) 205-213
4. Corpechot C., Young J., Calvel M., Wehrey C., Veltz J.N., Touyer G., et al. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133 (1993) 1003-1009
5. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38 (1992) 379-395
6. Lambert J.J., Belelli D., Hill-Venning, and Peters C.A. Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16 (1995) 295-303
7. Rupprecht R., and Holsboer F. Neuropsychopharmacological properties of neuroactive steroids. Steroids 64 (1999) 83-91
8. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., et al. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 86 (2003) 848-859
9. Genazzani A.R., Petraglia F., Bergamaschi M., Genazzani A.D., Facchinetti F., and Volpe A. Progesterone and progestins modulate β-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats. Gynecol Endocrinol 1 (1987) 61-69
10. Bernardi F., Pluchino N., Pieri M., Begliuomini S., Lenzi E., Puccetti S., et al. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology 83 (2006) 348-359
11. Genazzani A.R., Pluchino N., Begliuomini S., Pieri M., Centofanti M., Freschi L., et al. Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats. Menopause 14 (2007) 63-73
12. Bernardis L.L., and Davis P.J. Aging and the hypothalamus: research perspectives. Physiol Behav 59 (1996) 523-536
13. Coelingh Bennink H.J., and Boerrigter P.J. Use of dydrogesterone as a progestogen for oral contraception. Steroids 68 (2003) 927-929
14. Bernardi F., Salvestroni C., Casarosa E., Nappi R.E., Lanzone A., Luisi S., et al. Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. Eur J Endocrinol 138 (1998) 316-321
15. Bernardi F., Stomati M., Luisi S., Pieri M., Latrie F., and Genazzani A.R. Effects of the new generation selective estrogen modulator EM-652 and oral administration of estradiol valerate on circulating, brain and adrenal β-endorphin and allopregnanolone levels in intact fertile and ovariectomized rats. Fertil Steril 77 (2002) 1018-1027
16. Petraglia F., Penalva A., Locatelli V., Cocchi D., Panerai A.E., Genazzani A.R., et al. Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat. Endocrinology 111 (1982) 1224-1229
17. Genazzani A.R., Stomati M., Bernardi F., Luisi S., Casarosa E., Puccetti S., et al. Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil Steril 81 (2004) 757-766
18. Morse C.A., Dennerstein L., Farrell E., and Varnavides K. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome. J Behav Med 14 (1991) 469-489
19. Cagnacci A., Arangino S., Baldassari F., Alessandrini C., Landi S., and Volpe A. A comparison of the central effects of different progestins used in hormone replacement therapy. Maturitas 48 (2004) 456-462
20. Siddle N.C., Fraser D., Whitehead M.I., Jesinger D.K., Endacott J., Prescott P., et al. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone. Br J Obst Gynaecol 97 (1990) 1101-1107
21. Genazzani A.R., Bernardi F., Pluchino N., Begliuomini S., Lenzi E., Casarosa E., et al. Endocrinology of menopausal transition and its brain implications. CNS Spectr 10 (2005) 449-457
22. Frye C.A., and Walf A.A. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41 (2002) 306-315
23. Uzunova V., Ceci M., Kohler C., Uzunov D.P., and Wrynn A.S. Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression. Brain Res 976 (2003) 1-8
24. Bernardi F., Pieri M., Stomati M., Luisi S., Palumbo M., Pluchino N., et al. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 17 (2003) 65-77
25. Bernardi F., Pluchino N., Stomati M., Pieri M., and Genazzani A.R. CNS: sex steroids and SERMs. Ann NY Acad Sci 997 (2003) 378-388
26. Cheng Y.J., and Karavolas H.J. Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medial basal hypothalamus and the effects of estradiol and stage of estrus cycle on the conversion. Endocrinology 93 (1973) 1157-1162